PURPOSE: Radiation pneumonitis is the most severe dose-limiting complication in patients receiving thoracic radiation therapy. The aim of this study was to quantify global lung inflammation following radiation therapy using FDG PET/CT. METHODS: We studied 20 subjects with stage III non-small-cell lung carcinoma who had undergone FDG PET/CT imaging before and after radiation therapy. On all PET/CT studies, the sectional lung volume (sLV) of each lung was calculated from each slice by multiplying the lung area by slice thickness. The sectional lung glycolysis (sLG) was calculated by multiplying the sLV and the lung sectional mean standardized uptake value (sSUVmean) on each slice passing through the lung. The lung volume (LV) was calculated by adding all sLVs from the lung, and the global lung glycolysis (GLG) was calculated by adding all sLGs from the lung. Finally, the lung SUVmean was calculated by dividing the GLG by the LV. The amount of inflammation in the lung parenchyma directly receiving radiation therapy was calculated by subtracting tumor measurements from GLG. RESULTS: In the lung directly receiving radiation therapy, the lung parenchyma SUVmean and global lung parenchymal glycolysis were significantly increased following therapy. In the contralateral lung (internal control), no significant changes were observed in lung SUVmean or GLG following radiation therapy. CONCLUSION: Global lung parenchymal glycolysis and lung parenchymal SUVmean may serve as potentially useful biomarkers to quantify lung inflammation on FDG PET/CT following thoracic radiation therapy.
PURPOSE: Radiation pneumonitis is the most severe dose-limiting complication in patients receiving thoracic radiation therapy. The aim of this study was to quantify global lung inflammation following radiation therapy using FDG PET/CT. METHODS: We studied 20 subjects with stage III non-small-cell lung carcinoma who had undergone FDG PET/CT imaging before and after radiation therapy. On all PET/CT studies, the sectional lung volume (sLV) of each lung was calculated from each slice by multiplying the lung area by slice thickness. The sectional lung glycolysis (sLG) was calculated by multiplying the sLV and the lung sectional mean standardized uptake value (sSUVmean) on each slice passing through the lung. The lung volume (LV) was calculated by adding all sLVs from the lung, and the global lung glycolysis (GLG) was calculated by adding all sLGs from the lung. Finally, the lung SUVmean was calculated by dividing the GLG by the LV. The amount of inflammation in the lung parenchyma directly receiving radiation therapy was calculated by subtracting tumor measurements from GLG. RESULTS: In the lung directly receiving radiation therapy, the lung parenchyma SUVmean and global lung parenchymal glycolysis were significantly increased following therapy. In the contralateral lung (internal control), no significant changes were observed in lung SUVmean or GLG following radiation therapy. CONCLUSION: Global lung parenchymal glycolysis and lung parenchymal SUVmean may serve as potentially useful biomarkers to quantify lung inflammation on FDG PET/CT following thoracic radiation therapy.
Authors: Zafer Kocak; Elizabeth S Evans; Su-Min Zhou; Keith L Miller; Rodney J Folz; Timothy D Shafman; Lawrence B Marks Journal: Int J Radiat Oncol Biol Phys Date: 2005-07-01 Impact factor: 7.038
Authors: Michael P Mac Manus; Zhe Ding; Annette Hogg; Alan Herschtal; David Binns; David L Ball; Rodney J Hicks Journal: Int J Radiat Oncol Biol Phys Date: 2010-08-02 Impact factor: 7.038
Authors: F Hofheinz; C Pötzsch; L Oehme; B Beuthien-Baumann; J Steinbach; J Kotzerke; J van den Hoff Journal: Nuklearmedizin Date: 2011-10-26 Impact factor: 1.379
Authors: Deepak R Subramanian; Lee Jenkins; Ross Edgar; Nabil Quraishi; Robert A Stockley; David G Parr Journal: Am J Respir Crit Care Med Date: 2012-07-26 Impact factor: 21.405
Authors: Erik S Musiek; Babak Saboury; Shipra Mishra; Yufen Chen; Janet S Reddin; Andrew B Newberg; Jayaram K Udupa; John A Detre; Frank Hofheinz; Drew Torigian; Abass Alavi Journal: Hell J Nucl Med Date: 2012-10-25 Impact factor: 1.102
Authors: Alfredo E Echeverria; Matthew McCurdy; Richard Castillo; Vincent Bernard; Natalia Velez Ramos; William Buckley; Edward Castillo; Ping Liu; Josue Martinez; Thomas Guerrero Journal: Radiother Oncol Date: 2012-11-02 Impact factor: 6.280
Authors: Feng-Ming Spring Kong; Kirk A Frey; Leslie E Quint; Randall K Ten Haken; James A Hayman; Marc Kessler; Indrin J Chetty; Daniel Normolle; Avraham Eisbruch; Theodore S Lawrence Journal: J Clin Oncol Date: 2007-07-20 Impact factor: 44.544
Authors: Babak Saboury; Ali Salavati; Alex Brothers; Sandip Basu; Thomas C Kwee; Marnix G E H Lam; Roland Hustinx; Edouard Louis; Drew A Torigian; Abass Alavi Journal: Eur J Nucl Med Mol Imaging Date: 2013-11-20 Impact factor: 9.236
Authors: Michael MacManus; Sarah Everitt; Tanja Schimek-Jasch; X Allen Li; Ursula Nestle; Feng-Ming Spring Kong Journal: Transl Lung Cancer Res Date: 2017-12
Authors: Jinbo Yue; Qiuling Shi; Ting Xu; Melenda Jeter; Ting-Yu Chen; Ritsuko Komaki; Daniel R Gomez; Tinsu Pan; Charles S Cleeland; Zhongxing Liao; Xin Shelley Wang Journal: Qual Life Res Date: 2018-03-16 Impact factor: 4.147
Authors: Daniele Muser; Pasquale Santangeli; Simon A Castro; Jackson J Liang; Andres Enriquez; Thomas J Werner; Gaetano Nucifora; Silvia Magnani; Tatsuya Hayashi; Erica S Zado; Fermin C Garcia; David J Callans; Sanjay Dixit; Benoit Desjardins; Francis E Marchlinski; Abass Alavi Journal: Eur J Nucl Med Mol Imaging Date: 2018-04-02 Impact factor: 9.236